二叶式主动脉瓣修复:瓣膜失败原因与长期结局
研究回顾1993至2016年113例因显著主动脉瓣反流行二叶式主动脉瓣修复的患者,分析再手术原因并与主动脉瓣置换比较。
要点
- 瓣叶钙化或纤维化是二叶式主动脉瓣修复后失败的最常见原因(68%)
- 生物瓣置换后再手术风险与修复相似,机械瓣置换显示显著优势
核心结论
- 疾病进展导致的钙化或纤维化是二叶式主动脉瓣修复后瓣膜失败的最常见原因。
- 对于严重主动脉瓣反流,二叶式主动脉瓣修复的临床结局似乎优于生物瓣置换。
研究设计与样本
- 单中心回顾性研究,1993年1月至2016年12月共113例因显著主动脉瓣反流行二叶式主动脉瓣修复。
- 通过手术记录和病理报告识别修复失败的晚期原因,并采用基于梯度提升机模型的倾向评分加权与主动脉瓣置换患者比较。
主要发现
- 共26例患者初次修复后行晚期主动脉瓣置换。
- 晚期瓣膜功能障碍原因包括瓣叶钙化或纤维化(68%)、因合并中度主动脉瓣病变为预防未来手术而同期置换(20%)和瓣叶脱垂(12%)。
- 切除瓣膜的病理评估显示88%的瓣膜存在钙化和纤维化。
- 生物瓣置换后再手术发生率与修复后风险相似,而机械瓣置换显示显著优势。
临床怎么用
- 二叶式主动脉瓣修复可用于严重主动脉瓣反流,但需告知患者疾病进展导致钙化或纤维化是远期失败主因。
- 对于严重主动脉瓣反流,二叶式主动脉瓣修复的结局似乎优于生物瓣置换,选择生物瓣置换时应权衡再手术风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Repair of bicuspid aortic valves (BAVs) for aortic regurgitation (AR) has favorable outcomes, but the impact of natural disease progression on durability of repair is uncertain. We evaluated causes of reoperation and compared outcomes of BAV repair to those of patients undergoing aortic valve replacement (AVR). METHODS: Between January 1993 and December 2016, 113 patients had BAV repair at our institution for significant AR. Operative notes and pathology reports were studied to identify late causes of repair failure. For comparison with AVR, we utilized propensity score weighting with the score derived from preoperative and operative characteristics using gradient boosting machine model. RESULTS: A total of 26 patients had late AVR after initial repair. Causes of late valve dysfunction included calcification or fibrosis of the cusps (68%), concomitant replacement addressing moderate degree of aortic valve disease to avoid future operation (20%), and cusp prolapse (12%). Pathological evaluation of these excised valves reported calcification and fibrosis in 88% of the valves. Ten-year survival of patients undergoing BAV repair was 91% compared with 90% for patients undergoing AVR with a mechanical valve and 79% for AVR with a bioprosthesis (P = .6). Incidence of reoperation after AVR with a bioprosthesis was similar to risk after repair whereas AVR with mechanical valve showed significant advantage. CONCLUSIONS: Disease progression with calcification or fibrosis is the most common cause of valve failure after initial repair of BAV. Clinical outcomes of BAV repair for severe AR appear superior to AVR with bioprosthesis.
引用
- Patlolla SH, Schaff HV, Stulak JM, et al. Bicuspid Aortic Valve Repair: Causes of Valve Failure and Long-Term Outcomes. Ann Thorac Surg. 2020. PMID: 32599047. doi:10.1016/j.athoracsur.2020.04.146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。